CoChat

Obesity as an Emerging Risk Factor for Iron Deficiency

Open access

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.

Abstract

Iron homeostasis is affected by obesity and obesity-related insulin resistance in a many-facetted fashion. On one hand, iron deficiency and anemia are frequent findings in subjects with progressed stages of obesity. This phenomenon has been well studied in obese adolescents, women and subjects undergoing bariatric surgery. On the other hand, hyperferritinemia with normal or mildly elevated transferrin saturation is observed in approximately one-third of patients with metabolic syndrome (MetS) or nonalcoholic fatty liver disease (NAFLD). This constellation has been named the “dysmetabolic iron overload syndrome (DIOS)”. Both elevated body iron stores and iron deficiency are detrimental to health and to the course of obesity-related conditions. Iron deficiency and anemia may impair mitochondrial and cellular energy homeostasis and further increase inactivity and fatigue of obese subjects. Obesity-associated inflammation is tightly linked to iron deficiency and involves impaired duodenal iron absorption associated with low expression of duodenal ferroportin (FPN) along with elevated hepcidin concentrations. This review summarizes the current understanding of the dysregulation of iron homeostasis in obesity.

Overview

CoChat Summary

TL;DR

Obesity is linked to disordered iron homeostasis in a Janus-faced manner: iron deficiency and anemia are common in adolescents and severe obesity, while dysmetabolic iron overload syndrome (DIOS) affects about one-third of subjects with metabolic syndrome or NAFLD. The review attributes obesity-related iron deficiency mainly to adipose-tissue inflammation, elevated hepcidin, and impaired duodenal iron absorption.

Key findings

  • An NHANES analysis found the risk for iron deficiency, defined as low transferrin saturation and low serum ferritin, was twice as high in overweight adolescents compared with normal-weight adolescents.
  • DIOS affects approximately one-third of subjects with nonalcoholic fatty liver disease (NAFLD) or metabolic syndrome (MetS), characterized by increased serum ferritin with normal or mildly elevated transferrin saturation.
  • Before bariatric surgery, low iron and low ferritin serum concentrations are observed in 30% to 40% and 6% to 9% of patients, respectively; one year after RYGB, AGB, and SG, iron deficiency prevalence was estimated at 20%, 14%, and 15%, respectively.
  • The central mechanism proposed is impaired duodenal iron absorption, linked to elevated hepcidin, lower duodenal ferroportin expression, and obesity-associated inflammation; weight loss and restrictive bariatric surgery may improve functional iron status.

Methods

  • Narrative review summarizing current understanding of iron homeostasis dysregulation in obesity, with a main focus on iron deficiency and only relevant mention of DIOS.
  • Synthesizes clinical, pathophysiological, and mechanistic studies across adolescents, adults, bariatric surgery cohorts, and animal models; no primary data collection or systematic search is described.
  • Main analysis is qualitative synthesis, including two summary figures of potential stimuli and molecular links between obesity and iron deficiency.

Limitations

  • The paper states that data are relatively scarce regarding the relevance of iron deficiency to the course of obesity, and that no investigations have been performed on changes in iron homeostasis in subjects receiving the duodenal-jejunal bypass sleeve.
  • The paper notes that adult results are more complex than adolescent results, with some studies showing no differences in serum iron between obese and normal-weight controls.
  • Evident from the text: this is a narrative review without a described systematic search, quality appraisal, or meta-analytic synthesis, so conclusions depend on the selected cited literature.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu6093587

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Summary of potential stimuli and characteristics which may affect the manifestation of the iron phenotype in obesity. Both iron deficiency and the dysmetabolic iron overload syndrome represent well-studied manifestations of disordered iron homeostasis. The net balance of underlying, frequently competing stimuli will likely define the iron phenotype in an individual patient.
Figure 1 Summary of potential stimuli and characteristics which may affect the manifestation of the iron phenotype in obesity. Both iron deficiency and the dysmetabolic iron overload syndrome represent well-studied manifestations of disordered iron homeostasis. The net balance of underlying, frequently competing stimuli will likely define the iron phenotype in an individual patient.CC BY · PubMed Central
Figure 2 Current understanding of molecular links between obesity and iron deficiency. Obese adipose tissue is characterized by an increased production of several pro-inflammatory cytokines and adipokines as opposed to healthy lean adipose tissue. These may directly impact iron absorption from the enterocyte. Additionally, pro-inflammatory cytokines such as interleukin-1 and -6 represent potent inducers of hepcidin production in the liver, which may further impair iron absorption. Both cytokines and hepcidin lead to iron retention in spleen, liver or bone marrow macrophages, thereby lowering serum iron concentrations and iron availability for erythropoiesis.
Figure 2 Current understanding of molecular links between obesity and iron deficiency. Obese adipose tissue is characterized by an increased production of several pro-inflammatory cytokines and adipokines as opposed to healthy lean adipose tissue. These may directly impact iron absorption from the enterocyte. Additionally, pro-inflammatory cytokines such as interleukin-1 and -6 represent potent inducers of hepcidin production in the liver, which may further impair iron absorption. Both cytokines and hepcidin lead to iron retention in spleen, liver or bone marrow macrophages, thereby lowering serum iron concentrations and iron availability for erythropoiesis.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 2 Not valid · 5 Not checked · 14 Own results and interpretations

10 more claims

Create a free account to see all 22 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 6
  • Probably not a substantial claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 82 references

Cited by

Items 301–326 of 326

Metadata

Authors
Aigner, E., Feldman, A., & Datz, C.
Affiliations
Paracelsus Medical University (AT)
Corresponding author
  • Aigner, Elmar
  • Datz, Christian
Venue
Nutrients
Publisher
MDPI AG
Published
2014-09-11
Volume
6
Issue
9
Pages
3587-3600
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2071176238
Cited by
328
References
82
Citations by year
2026: 21 · 2025: 22 · 2024: 24 · 2023: 25 · 2022: 32 · 2021: 49 · 2020: 53 · 2019: 23 · 2018: 20 · 2017: 22 · 2016: 15 · 2015: 20 · 2014: 1
FWCI
2.95
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Paracelsus-Forschungsförderungsfonds (E-13/17/086-AIG)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
obesity, iron deficiency, iron homeostasis, anemia, insulin resistance, hyperferritinemia, metabolic syndrome, non-alcoholic fatty liver disease, hepcidin, ferroportin, duodenal iron absorption, inflammation, bariatric surgery, adolescents
MeSH terms
Iron Deficiencies, Humans, Intestinal Absorption, Iron, Nutritional Status, Obesity, Anemia, Iron-Deficiency, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.